The past decade has seen a significant shift in the nature of the products being manufactured and sold by the innovative biopharmaceutical (biopharma) industry.
Pharmaceutical Industry White Papers
'White Papers' is specialized section provide real, actionable information to prospects. Done well, they shorten sales cycles, educate prospects and showcase a company’s thought leadership. White papers are hosted behind a registration-based landing page that captures key lead scoring information.
White Paper publication program on pharmatechglobal.net benefit from our integrated audience database. Registration can be pre-populated based on our database of professionals, providing for superior conversion rates. — If interested, Post your company's White Papers here
Pharmaceutical companies have to contend with challenges stemming from supply chain security lapses (resulting in theft, diversion and product recalls), counterfeiting and stringent regulations. In addition to alarming safety concerns, these challenges also impair the health of the industry by adversely impacting profits, brand credibility and research initiatives.
Emerging markets are a big opportunity for pharma companies. But from the R&D productivity standpoint, these markets create new challenges in genomic complexity. So, in research and clinic development process, trials need to be more inclusive taking into context the wider population that the companies will have to deal with..
Aerogen’s vibrating mesh nebuliser technology, available within the Aerogen® Solo, Pro and also the NIVO, has been adopted for use across many areas of the hospital during a variety of ventilatory support including conventional mechanical ventilation, high frequency oscillatory ventilation, noninvasive ventilation and nasal high flow.